Cormay Diagnostics makes affordable to small and mid-size clinical laboratories all over the world the cutting-edge technology and performance demanded by large clinical laboratories.
Combining the 35-years experienced manufacturer of reagents, Cormay with the outstanding technology knowledge of Swiss hematology company, Orphee, we work together every day to build the IVD brand that can be trusted.
Your trust is in the core of everything we do.
1985
Served areaWorldwide
HeadquartersPuławska 303, 02-785 Warszawa – Poland
Line item in (pln) | 02.01.2020 | 01.01.2021 | 02.01.2021 | 01.01.2022 | 01.01.2023 |
---|---|---|---|---|---|
Assets | N/A | 93,740,000.00 | N/A | 99,687,000.00 | 101,975,000.00 |
Noncurrent Assets | N/A | 29,823,000.00 | N/A | 36,247,000.00 | 43,074,000.00 |
Property Plant And Equipment | N/A | 11,038,000.00 | N/A | 15,583,000.00 | 17,463,000.00 |
Goodwill | N/A | 0.00 | N/A | 0.00 | 0.00 |
Intangible Assets Other Than Goodwill | N/A | 14,085,000.00 | N/A | 15,853,000.00 | 20,555,000.00 |
Noncurrent Receivables | N/A | 235,000.00 | N/A | 49,000.00 | 52,000.00 |
Deferred Tax Assets | N/A | 773,000.00 | N/A | 1,081,000.00 | 1,181,000.00 |
Current Assets | N/A | 63,917,000.00 | N/A | 63,440,000.00 | 58,901,000.00 |
Inventories | N/A | 15,168,000.00 | N/A | 18,587,000.00 | 26,793,000.00 |
Trade And Other Current Receivables | N/A | 12,864,000.00 | N/A | 14,235,000.00 | 17,161,000.00 |
Other Current Financial Assets | N/A | 26,148,000.00 | N/A | 28,112,000.00 | 13,655,000.00 |
Cash and cash equivalents | 7,260,000.00 | 9,737,000.00 | 9,737,000.00 | 2,506,000.00 | 1,292,000.00 |
Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 63,917,000.00 | N/A | 63,440,000.00 | 58,901,000.00 |
Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 0.00 | N/A | 0.00 | 0.00 |
Equity And Liabilities | N/A | 93,740,000.00 | N/A | 99,687,000.00 | 101,975,000.00 |
Equity | 73,818,000.00 | 63,316,000.00 | 62,964,000.00 | 65,351,000.00 | 61,756,000.00 |
Issued Capital | N/A | 84,205,000.00 | N/A | 84,205,000.00 | 84,205,000.00 |
Retained Earnings | N/A | -117,910,000.00 | N/A | -116,626,000.00 | -123,195,000.00 |
Share Premium | N/A | 92,811,000.00 | N/A | 92,811,000.00 | 92,811,000.00 |
Other Reserves | N/A | 3,330,000.00 | N/A | 4,110,000.00 | 7,439,000.00 |
Equity Attributable To Owners Of Parent | N/A | 62,436,000.00 | N/A | 64,500,000.00 | 61,260,000.00 |
Noncontrolling Interests | N/A | 880,000.00 | N/A | 851,000.00 | 496,000.00 |
Liabilities | N/A | 30,424,000.00 | N/A | 34,336,000.00 | 40,219,000.00 |
Noncurrent Liabilities | N/A | 5,118,000.00 | N/A | 4,412,000.00 | 4,395,000.00 |
Noncurrent Provisions For Employee Benefits | N/A | 199,000.00 | N/A | 250,000.00 | 192,000.00 |
Deferred Tax Liabilities | N/A | 612,000.00 | N/A | 550,000.00 | 705,000.00 |
Other Noncurrent Financial Liabilities | N/A | 3,071,000.00 | N/A | 2,818,000.00 | 2,862,000.00 |
Other Noncurrent Nonfinancial Liabilities | N/A | 1,236,000.00 | N/A | 794,000.00 | 636,000.00 |
Current Liabilities | N/A | 25,306,000.00 | N/A | 29,924,000.00 | 35,824,000.00 |
Current Provisions For Employee Benefits | N/A | 673,000.00 | N/A | 636,000.00 | 641,000.00 |
Other Shortterm Provisions | N/A | 12,547,000.00 | N/A | 13,772,000.00 | 13,165,000.00 |
Trade And Other Current Payables | N/A | 10,496,000.00 | N/A | 14,015,000.00 | 20,648,000.00 |
Current Tax Liabilities Current | N/A | 0.00 | N/A | 0.00 | 0.00 |
Other Current Financial Liabilities | N/A | 1,574,000.00 | N/A | 1,273,000.00 | 1,212,000.00 |
Other Current Nonfinancial Liabilities | N/A | 16,000.00 | N/A | 228,000.00 | 158,000.00 |
Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 25,306,000.00 | N/A | 29,924,000.00 | 35,824,000.00 |
Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 0.00 | N/A | 0.00 | 0.00 |
Line item in (pln) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
---|---|---|---|
Revenue | 65,290,000.00 | 84,732,000.00 | 85,361,000.00 |
Other Income | 2,769,000.00 | 1,855,000.00 | 1,650,000.00 |
Profit Loss From Operating Activities | -7,304,000.00 | -68,000.00 | -4,314,000.00 |
Finance Income | 1,176,000.00 | 3,946,000.00 | 3,156,000.00 |
Finance Costs | 6,694,000.00 | 1,965,000.00 | 4,847,000.00 |
Impairment Loss Impairment Gain And Reversal Of Impairment Loss Determined In Accordance With I F R S9 | -121,000.00 | 156,000.00 | 237,000.00 |
Profit Loss Before Tax | -12,701,000.00 | 1,757,000.00 | -6,242,000.00 |
Income Tax Expense Continuing Operations | 120,000.00 | 79,000.00 | 402,000.00 |
Profit Loss From Continuing Operations | -12,821,000.00 | 1,678,000.00 | -6,644,000.00 |
Profit Loss From Discontinued Operations | 0.00 | 0.00 | 0.00 |
Profit (loss) | -12,821,000.00 | 1,678,000.00 | -6,644,000.00 |
Profit Loss Attributable To Owners Of Parent | -12,665,000.00 | 1,635,000.00 | -6,568,000.00 |
Profit Loss Attributable To Noncontrolling Interests | -156,000.00 | 43,000.00 | -76,000.00 |
Line item in (pln) | 01.01.2021 | 02.01.2020 | 01.01.2022 | 02.01.2021 | 01.01.2023 |
---|---|---|---|---|---|
Profit (loss) | -12,821,000.00 | N/A | 1,678,000.00 | N/A | -6,644,000.00 |
Adjustments For Reconcile Profit Loss | 12,606,000.00 | N/A | -2,960,000.00 | N/A | -2,008,000.00 |
Adjustments For Income Tax Expense | 120,000.00 | N/A | 79,000.00 | N/A | 402,000.00 |
Adjustments For Finance Costs | 1,258,000.00 | N/A | 490,000.00 | N/A | 1,432,000.00 |
Adjustments For Decrease Increase In Inventories | 1,481,000.00 | N/A | -7,077,000.00 | N/A | -9,664,000.00 |
Adjustments For Decrease Increase In Other Operating Receivables | 767,000.00 | N/A | -145,000.00 | N/A | N/A |
Adjustments For Increase Decrease In Trade Account Payable | -4,101,000.00 | N/A | 2,582,000.00 | N/A | 5,797,000.00 |
Adjustments For Increase Decrease In Other Operating Payables | 1,932,000.00 | N/A | -230,000.00 | N/A | -434,000.00 |
Adjustments For Depreciation And Amortisation Expense | 4,316,000.00 | N/A | 4,339,000.00 | N/A | 4,606,000.00 |
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 5,480,000.00 | N/A | 229,000.00 | N/A | 200,000.00 |
Adjustments For Provisions | 1,075,000.00 | N/A | 740,000.00 | N/A | -972,000.00 |
Adjustments For Fair Value Gains Losses | 1,950,000.00 | N/A | -2,508,000.00 | N/A | 1,246,000.00 |
Other Adjustments For Noncash Items | N/A | N/A | -558,000.00 | N/A | -167,000.00 |
Adjustments For Losses Gains On Disposal Of Noncurrent Assets | -292,000.00 | N/A | -290,000.00 | N/A | N/A |
Other Adjustments For Which Cash Effects Are Investing Or Financing Cash Flow | N/A | N/A | -290,000.00 | N/A | -3,160,000.00 |
Other Adjustments To Reconcile Profit Loss | -590,000.00 | N/A | -558,000.00 | N/A | N/A |
Adjustments For Reconcile Profit Loss | 12,606,000.00 | N/A | -2,960,000.00 | N/A | -2,008,000.00 |
Cash Flows From Used In Operations | -215,000.00 | N/A | -1,282,000.00 | N/A | -8,652,000.00 |
Income Taxes Paid Refund Classified As Operating Activities | -54,000.00 | N/A | 187,000.00 | N/A | 57,000.00 |
Cash Flows From Used In Operating Activities | -161,000.00 | N/A | -1,469,000.00 | N/A | -8,709,000.00 |
Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | 0.00 | N/A | 0.00 | N/A | N/A |
Other Cash Payments To Acquire Equity Or Debt Instruments Of Other Entities Classified As Investing Activities | 7,000,000.00 | N/A | 0.00 | N/A | N/A |
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | 221,000.00 | N/A | 61,000.00 | N/A | 24,000.00 |
Purchase Of Property Plant And Equipment Classified As Investing Activities | 183,000.00 | N/A | 4,446,000.00 | N/A | 2,483,000.00 |
Proceeds From Sales Of Intangible Assets Classified As Investing Activities | N/A | N/A | 0.00 | N/A | 52,000.00 |
Purchase Of Intangible Assets Classified As Investing Activities | 4,480,000.00 | N/A | 2,300,000.00 | N/A | 5,952,000.00 |
Proceeds From Other Longterm Assets Classified As Investing Activities | 11,596,000.00 | N/A | 2,000,000.00 | N/A | 17,122,000.00 |
Proceeds From Government Grants Classified As Investing Activities | 743,000.00 | N/A | 0.00 | N/A | 206,000.00 |
Other Inflows Outflows Of Cash Classified As Investing Activities | -743,000.00 | N/A | -39,000.00 | N/A | 0.00 |
Cash Flows From Used In Investing Activities | 154,000.00 | N/A | -4,724,000.00 | N/A | 8,969,000.00 |
Payments From Changes In Ownership Interests In Subsidiaries | 375,000.00 | N/A | 0.00 | N/A | N/A |
Proceeds From Borrowings Classified As Financing Activities | 3,747,000.00 | N/A | 1,337,000.00 | N/A | 493,000.00 |
Repayments Of Borrowings Classified As Financing Activities | 0.00 | N/A | 223,000.00 | N/A | 535,000.00 |
Payments Of Lease Liabilities Classified As Financing Activities | 938,000.00 | N/A | 1,273,000.00 | N/A | 918,000.00 |
Dividends Paid Classified As Financing Activities | 178,000.00 | N/A | 279,000.00 | N/A | 5,000.00 |
Interest Paid Classified As Financing Activities | 126,000.00 | N/A | 181,000.00 | N/A | 372,000.00 |
Cash Flows From Used In Financing Activities | 2,130,000.00 | N/A | -619,000.00 | N/A | -1,337,000.00 |
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 2,123,000.00 | N/A | -6,812,000.00 | N/A | -1,077,000.00 |
Effect Of Exchange Rate Changes On Cash And Cash Equivalents | 354,000.00 | N/A | -419,000.00 | N/A | -137,000.00 |
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 2,477,000.00 | N/A | -7,231,000.00 | N/A | -1,214,000.00 |
Cash and cash equivalents | 9,737,000.00 | 7,260,000.00 | 2,506,000.00 | 9,737,000.00 | 1,292,000.00 |
Please note that some sums might not add up.
PLCMRAY00029
LEI2594006HZJ8OSNK56U87
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.